Impax Laboratories Inc

Type: Company
Name: Impax Laboratories Inc
Nationality: United States
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Dr Reddys Laboratories (RDY, IPXL, RHHBY, AKRX, AZN)

Written on Fri, 09/19/2014 - 9:29amBy Shiri GuptaWe looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look ... [Published Comtex SmarTrend - Sep 19 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

FDA delays decision on Impax Parkinson's drug

An FDA decision on a treatment for Parkinson's disease symptoms — the first non-generic drug developed by Impax Laboratories Inc. — has been pushed back three months to January.The Hayward-based drug maker (NASDAQ: IPXL) blamed the delay on changes it ... [Published San Francisco Business Times - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 5 reports

Impax Pharmaceuticals Announces Extension of RYTARY FDA Review Date To January 9, 2015

Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and ... ... [Published Austin American Statesman - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

CT AG investigating heart drug pricing

State Attorney General George Jepsen is investigating the pricing practices of at least two companies that manufacturer a generic heart drug called digoxin, according to filings with the U.S. Securities and Exchange Commission.Lannett Company Inc., a ... [Published Hartford Business Journal - Sep 16 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Deadline in Lawsuit for Investors in Impax Laboratories Inc (IPXL) Shares Announced by Shareholders Foundation

SAN DIEGO, Sept. 16, 2014 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Impax Laboratories Inc (IPXL) over alleged Violations of Federal Securities Laws by Impax Laboratories ... [Published Nation's Restaurant News - Sep 16 2014]
First reported Sep 09 2014 - Updated Sep 10 2014 - 1 reports

Stock Investors Sell Off Shares of Impax Laboratories, Down 2.0%

One of today's stocks on the move is Impax Laboratories (NASDAQ:IPXL), down 2.0% to $24.37. The Dow Jones Industrial Average is now trading 0.4% lower to 17,037 and the S&P is trading 0.4% lower to 1,994. ... [Published Individual.com - Sep 09 2014]
First reported Sep 08 2014 - Updated Sep 08 2014 - 4 reports

INVESTOR ALERT: Class Action Lawsuit Against Impax Laboratories, Inc. Announced by Law Offices of Howard G. Smith

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of…Click to Continue » ... [Published Fort Mills Times - Sep 08 2014]
First reported Aug 28 2014 - Updated Aug 29 2014 - 2 reports

Armetheon pulls in $7M to enter new trials for blood thinning drug

Biopharmaceutical startup Armetheon Inc. has brought in $7 million in funding to continue testing Tecarfarin, the company's late-stage oral anticoagulant or blood thinner.The Series A round was led by AshHill Biomedical Investments and Hercules Bioventures ... [Published Business First of Buffalo - Aug 29 2014]
First reported Aug 28 2014 - Updated Aug 28 2014 - 1 reports

Shares of Impax Laboratories Underperfor...

Below are five companies in the Pharmaceuticals industry that underperformed yesterday on a relative basis. This analysis was compiled based on yesterday's trading activity as we search for stocks that have could possible underperform its peers going ... [Published Financial News Network online - Aug 28 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 4 reports

INVESTOR ALERT: Class Action Lawsuit Against Impax Laboratories, Inc. Filed by Glancy Binkow & Goldberg LLP

Glancy Binkow & Goldberg LLP , representing investors of Impax Laboratories, Inc. (“Impax” or the “Company”) (NASDAQ:IPXL), has filed a class action lawsuit in the United States District Court for…Click to Continue » ... [Published Fort Mills Times - Aug 27 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

Possible Lawsuit: Impax Laboratories, Inc 401(k) / ERISA Lawsuit

Home Page >> Potential Lawsuit >> Impax Laboratories, IncImpax Laboratories, Inc IPXL 401(k) / ERISA LawsuitImpax Laboratories, Inc has been accused of securities fraud. If you are a current or former employee or are a member of any of Impax ... [Published Lawyers & Settlements - Aug 25 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 5 reports

Lieff Cabraser Announces Class Action Litigation Against Impax Laboratories, Inc. - IPXL

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been brought on behalf of those who purchased or otherwise acquired the securities of…Click to Continue » ... [Published Fort Mills Times - Aug 25 2014]

Quotes

...to patients who are suffering from Parkinson's disease," said Fred Wilkinson, president and chief executive officer of Impax Laboratories Inc. "In addition, we are progressing towards our goal of filing the Marketing Authorization Application with the European Medical Agency later this year."
...a major U S distributor of the drug, said Tuesday that it had conducted an internal review of its pricing practices and determined that it "acted in compliance with applicable laws and regulations with regard to the pricing of digoxin."
IHE tracks the Dow Jones U S Select Pharmaceutical Index, which is a "float-adjusted market capitalization subject to caps on the weights of the largest securities."
...Jack Lew called for prompt action to stem the surge of U S businesses reincorporating abroad and said the Treasury Department was evaluating "what we can do to make these deals less economically appealing, and we plan to make a decision in the very near future."

More Content

All (142) | News (62) | Reports (0) | Blogs (55) | Audio/Video (0) | Fact Sheets (0) | Press Releases (25)
sort by: Date | Relevance
Best Relative Performance in the Pharmaceutical... [Published Comtex SmarTrend - Sep 19 2014]
Impax Rytary FDA Action Date Extended by Three ... [Published Zacks.com - Sep 18 2014]
FDA delays decision on Impax Parkinson's drug [Published San Francisco Business Times - Sep 17 2014]
Biggest Movers in Healthcare Stocks Now – AUXL ... [Published InvestorPlace.com - Sep 17 2014]
Impax Pharmaceuticals Announces Extension of RY... [Published Austin American Statesman - Sep 17 2014]
Impax Pharmaceuticals Announces Extension of RY... [Published Benzinga.com - Sep 17 2014]
Impax Pharma: FDA Extends PDUFA Date For Review... [Published RTTNews.com - Sep 17 2014]
Impax Pharmaceuticals Announces Extension of RY... [Published ADVFN India - Sep 17 2014]
Impax Pharmaceuticals Announces Extension of RY... [Published PR Newswire: Health - Sep 17 2014]
Hottest Healthcare Stocks Now – HTWR CNC PCRX INCY [Published InvestorPlace.com - Sep 17 2014]
CT AG investigating heart drug pricing [Published Hartford Business Journal - Sep 16 2014]
Deadline in Lawsuit for Investors in Impax Labo... [Published GlobeNewswire: Acquisitions News - Sep 16 2014]
Deadline in Lawsuit for Investors in Impax Labo... [Published Nation's Restaurant News - Sep 16 2014]
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Remind... [Published GlobeNewswire: Advertising News - Sep 15 2014]
Hagens Berman Reminds Investors in Impax Labora... [Published GlobeNewswire: Advertising News - Sep 15 2014]
Akorn said eyeing tax inversion [Published Yahoo! Finance - Sep 13 2014]
SHAREHOLDER ALERT: Brower Piven Encourages Inve... [Published EON Business - Sep 12 2014]
SHAREHOLDER ALERT: Brower Piven Encourages Inve... [Published Business Wire Professional Services News - Sep 12 2014]
SHAREHOLDER ALERT: Brower Piven Encourages Inve... [Published ad-hoc-news.de - Sep 12 2014]
Akorn Joins Tax Inversion Bandwagon [Published Bidness Etc - Sep 12 2014]
SHAREHOLDER ALERT: Pomerantz Law Firm Announces... [Published Financial Services - Sep 12 2014]
The Best Pharma ETF [Published BioPortfolio - Sep 12 2014]
With inversion pushback mounting, Akorn eyes bi... [Published FiercePharma - Sep 12 2014]
EXCLUSIVE-Akorn eyes $2 bln UCB unit in potenti... [Published CNBC - Sep 11 2014]
Morgan & Morgan Reminds Investors That a Class ... [Published GlobeNewswire: Acquisitions News - Sep 11 2014]
Morgan & Morgan Reminds Investors That a Class ... [Published CW Atlanta - Sep 11 2014]
Stock Investors Sell Off Shares of Impax Labora... [Published Individual.com - Sep 09 2014]
BUPROPION HYDROCHLORIDE Tablet, Film Coated, Ex... [Published DailyMed Drug Label Updates for the last seven ... - Sep 08 2014]
INVESTOR ALERT: Class Action Lawsuit Against Im... [Published Fort Mills Times - Sep 08 2014]
INVESTOR ALERT: Class Action Lawsuit Against Im... [Published Digital Journal - Sep 08 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Impax Pharmaceuticals Announces Extension of RY... [Published PR Newswire: Health - Sep 17 2014]
HAYWARD, Calif., Sept. 17, 2014 /PRNewswire/ -- Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee ...
SHAREHOLDER ALERT: Brower Piven Encourages Inve... [Published EON Business - Sep 12 2014]
STEVENSON, Md.--(EON: Enhanced Online News)--The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on ...
SHAREHOLDER ALERT: Brower Piven Encourages Inve... [Published Business Wire Professional Services News - Sep 12 2014]
STEVENSON, Md.--(BUSINESS WIRE)--The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers ...
SHAREHOLDER ALERT: Brower Piven Encourages Inve... [Published ad-hoc-news.de - Sep 12 2014]
The securities litigation law firm of Brower Piven, A ProfessionalCorporation, announces that a class action lawsuit has been commenced inthe United States District Court for the District of New Jersey onbehalf of purchasers ? ...
BUPROPION HYDROCHLORIDE Tablet, Film Coated, Ex... [Published DailyMed Drug Label Updates for the last seven ... - Sep 08 2014]
Updated Date: Sep 8, 2014 EST ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Deadline in Lawsuit for Investors in Impax Labo... [Published GlobeNewswire: Acquisitions News - Sep 16 2014]
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Remind... [Published GlobeNewswire: Advertising News - Sep 15 2014]
Hagens Berman Reminds Investors in Impax Labora... [Published GlobeNewswire: Advertising News - Sep 15 2014]
SHAREHOLDER ALERT: Pomerantz Law Firm Announces... [Published Financial Services - Sep 12 2014]
Morgan & Morgan Reminds Investors That a Class ... [Published GlobeNewswire: Acquisitions News - Sep 11 2014]
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.